Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Vestor Capital LLC

Vestor Capital LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 16.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 289,038 shares of the company's stock after acquiring an additional 41,692 shares during the period. Cardinal Health makes up about 2.8% of Vestor Capital LLC's investment portfolio, making the stock its 8th largest position. Vestor Capital LLC owned approximately 0.12% of Cardinal Health worth $29,135,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Ameriprise Financial Inc. raised its position in shares of Cardinal Health by 82.2% during the third quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company's stock worth $358,390,000 after purchasing an additional 1,862,291 shares during the period. Northern Trust Corp lifted its stake in Cardinal Health by 0.9% during the third quarter. Northern Trust Corp now owns 3,340,547 shares of the company's stock valued at $290,026,000 after buying an additional 28,412 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in shares of Cardinal Health by 17.5% in the fourth quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company's stock worth $264,052,000 after buying an additional 389,431 shares during the period. AQR Capital Management LLC increased its position in shares of Cardinal Health by 0.8% in the third quarter. AQR Capital Management LLC now owns 2,496,531 shares of the company's stock worth $216,749,000 after acquiring an additional 19,287 shares in the last quarter. Finally, California Public Employees Retirement System raised its holdings in shares of Cardinal Health by 118.9% during the fourth quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company's stock valued at $152,816,000 after acquiring an additional 823,520 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Trading Up 1.5 %

Shares of Cardinal Health stock traded up $1.47 during mid-day trading on Friday, reaching $99.53. 1,718,991 shares of the stock were exchanged, compared to its average volume of 2,273,211. Cardinal Health, Inc. has a fifty-two week low of $80.90 and a fifty-two week high of $116.04. The company has a market cap of $24.24 billion, a price-to-earnings ratio of 43.58, a price-to-earnings-growth ratio of 1.01 and a beta of 0.71. The firm has a 50-day simple moving average of $108.11 and a 200 day simple moving average of $105.16.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.95 by $0.13. The company had revenue of $54.90 billion during the quarter, compared to analysts' expectations of $56.05 billion. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. Cardinal Health's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.74 earnings per share. On average, research analysts predict that Cardinal Health, Inc. will post 7.34 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be issued a dividend of $0.5056 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Monday, July 1st. This represents a $2.02 annualized dividend and a yield of 2.03%. Cardinal Health's dividend payout ratio is currently 88.89%.

Analyst Ratings Changes

Several research firms have weighed in on CAH. SVB Leerink assumed coverage on shares of Cardinal Health in a research report on Monday, February 26th. They set an "outperform" rating and a $125.00 price objective on the stock. Wells Fargo & Company reduced their price objective on Cardinal Health from $96.00 to $94.00 and set an "underweight" rating for the company in a research note on Monday, April 29th. UBS Group upped their target price on Cardinal Health from $122.00 to $125.00 and gave the company a "buy" rating in a report on Monday, February 5th. Robert W. Baird decreased their target price on shares of Cardinal Health from $134.00 to $128.00 and set an "outperform" rating for the company in a research note on Friday, May 3rd. Finally, Argus raised Cardinal Health from a "hold" rating to a "buy" rating in a research report on Friday, February 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $107.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.